A 10% increase or decrease in value of Australia dollar against the above currencies at 30 June would have an immaterial effect.

FAIR VALUE MEASUREMENT OF FINANCIAL INSTRUMENTS

All assets and liabilities for which fair value is measured or disclosed in the nancial statements are categorised within the fair value

hierarchy, as described at note 1o).

The following table presents the Group’s nancial assets and liabilities measured and recognised at fair value.

Foreign currency risk

The group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily with

respect to the GBP (£), Euro (€) and CZK (Kč).

Foreign exchange risk arises from future commercial transactions and recognised assets and liabilities denominated in a currency that is

not the entity’s functional currency. The risk is measured using cash ow forecasting.

The consolidated entity has not entered into any derivative nancial instruments to hedge such transactions and anticipated future

receipts or payments that are denominated in a foreign currency. The board manages the purchase of foreign currency to meet

operational requirements.

The consolidate entity’s exposure to foreign currency risk at the reporting date was as follows:

Notes to the Financial Statements

mgcpharma.com.au